Ardelyx Current Deferred Revenue Over Time

ARDX Stock  USD 7.85  0.06  0.77%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Ardelyx Performance and Ardelyx Correlation.
For more information on how to buy Ardelyx Stock please use our How to Invest in Ardelyx guide.
  
Current Deferred Revenue is likely to drop to about 7 M in 2024.
Is Ardelyx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ardelyx. If investors know Ardelyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ardelyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.28)
Revenue Per Share
0.705
Quarterly Revenue Growth
3.048
Return On Assets
(0.14)
Return On Equity
(0.48)
The market value of Ardelyx is measured differently than its book value, which is the value of Ardelyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ardelyx's value that differs from its market value or its book value, called intrinsic value, which is Ardelyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ardelyx's market value can be influenced by many factors that don't directly affect Ardelyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ardelyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ardelyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ardelyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Current Deferred Revenue Analysis

Compare Ardelyx and related stocks such as BioLineRx, Lexicon Pharmaceuticals, and Seres Therapeutics Current Deferred Revenue Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
BLRX1.6 M1.6 M683.6 K1.1 M1.1 M1.1 M963 K1.1 M1.3 M1.3 MK13 M13 M14.9 M15.6 M
LXRX(9.4 M)119 K128 K195 K1.6 M76.5 M63.4 M40.1 M3.4 M28.2 M28.2 M28.2 M28.2 M32.4 M20 M
MCRB248 K248 K248 K248 K1.5 M12.1 M12.1 M12.1 M20.4 M25.8 M22.6 M16.8 M4.3 M7.7 M13.6 M
IBRX573 K573 K573 K573 K521 K228 K187 K166 K100 K100 K100 K100 K100 K90 K85.5 K
ZURA(355.6 K)(355.6 K)(355.6 K)(355.6 K)(355.6 K)(355.6 K)(355.6 K)(355.6 K)(355.6 K)(355.6 K)(355.6 K)(355.6 K)(355.6 K)(320 K)(336 K)
HEPA2.5 M2.5 M2.5 M2.5 M2.5 M2.5 M2.5 M2.5 M2.5 M2.5 M2.5 M2.5 M4.8 M2.4 M2.6 M
VSTM19.4 M19.4 M19.4 M19.4 M19.4 M19.4 M19.4 M19.4 M19.4 M19.4 M710 K710 K710 K327 K310.6 K
MREO(163.7 K)(163.7 K)(163.7 K)(163.7 K)(163.7 K)(163.7 K)(163.7 K)(163.7 K)(177.7 K)5.4 M8.4 M8.4 M6.5 M7.4 M4.4 M
TERN836 K836 K836 K836 K836 K836 K836 K836 K836 K836 K836 K1.2 M1.2 M1.4 M1.1 M
PDSB(265.3 K)(265.3 K)(265.3 K)(265.3 K)(265.3 K)(265.3 K)(265.3 K)(265.3 K)(265.3 K)(265.3 K)(265.3 K)(265.3 K)(265.3 K)(238.7 K)(250.7 K)
INZY279 K279 K279 K279 K279 K279 K279 K279 K279 K279 K279 K3.8 M3.8 M4.4 M2.2 M
HOOK725 K725 K725 K725 K725 K725 K725 K725 K7.5 M3.6 M4.6 M6.2 M16 M14.7 M8.4 M

Ardelyx and related stocks such as BioLineRx, Lexicon Pharmaceuticals, and Seres Therapeutics Current Deferred Revenue description

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

My Equities

My Current Equities and Potential Positions

Ardelyx
ARDX
ClassificationBiotech
LocationCalifornia; U.S.A
ExchangeNASDAQ Exchange
USD 7.85
When determining whether Ardelyx offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ardelyx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ardelyx Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ardelyx Stock:
Check out Ardelyx Performance and Ardelyx Correlation.
For more information on how to buy Ardelyx Stock please use our How to Invest in Ardelyx guide.
Note that the Ardelyx information on this page should be used as a complementary analysis to other Ardelyx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Ardelyx Stock analysis

When running Ardelyx's price analysis, check to measure Ardelyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ardelyx is operating at the current time. Most of Ardelyx's value examination focuses on studying past and present price action to predict the probability of Ardelyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ardelyx's price. Additionally, you may evaluate how the addition of Ardelyx to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Ardelyx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Ardelyx technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Ardelyx trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...